Russia presents updated state pharmaceutical strategy Pharma-2030

The Russia government has updated the existing draft strategy for the development of the domestic pharmaceutical industry - Pharma-2030, reports The Pharma Letter’s local correspondent.

As follows from the new version of the document, by 2030 the value of the Russian pharmaceutical market should reach 3.7 trillion roubles ($45.5 billion), and the share of domestically produced drugs will be 42.6%.

Th document states that the government positively assessed the results of the previous Pharma-2020 strategy, believing that it allowed to increase the volume of drug production in the country by 533.3% - from 96 billion roubles up to 607.9 billion roubles during the period of 2009-2022.